Castle Creek Pharmaceuticals Announces First Patient Enrolled in DELIVERS Study of Diacerein 1% Ointment for Epidermolysis Bullosa Simplex

International randomized, double-blind, parallel group Phase 2/3 clinical trial to evaluate safety and efficacy of potentially disease-modifying therapy PARSIPPANY, NJ [...]